U.S. fund to invest $20M in Korean firm’s anti-coronavirus technology
November 12, 2021 at 10:24 AM EST
South Korean startup Haim Bio announced that a U.S. fund operated by A&P Partners had agreed to invest $20 million in its anti-coronavirus technology.
